Rituximab in the treatment of recalcitrant generalized lupus erythematosus tumidus

J Dtsch Dermatol Ges. 2017 Jul;15(7):729-731. doi: 10.1111/ddg.13266. Epub 2017 Jun 9.

Authors

Alexander Kreuter¹, Christian Tigges¹, Nicolas Hunzelmann², Frank Oellig³, Percy Lehmann⁴, Silke C Hofmann⁴

Affiliations

¹ Department of Dermatology, Venereology, and Allergology, HELIOS St. Elisabeth Hospital Oberhausen, University of Witten--Herdecke, Oberhausen, Germany.
² Department of Dermatology and Venereology, University of Cologne, Cologne, Germany.
³ Pathology Institute Rhein-Ruhr, Mülheim an der Ruhr, Germany.
⁴ Department of Dermatology, Allergy and Dermatosurgery, HELIOS Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany.

PMID: 28598547
DOI: 10.1111/ddg.13266

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Disease Progression
Facial Dermatoses / diagnosis
Facial Dermatoses / drug therapy*
Follow-Up Studies
Humans
Lupus Erythematosus, Discoid / diagnosis
Lupus Erythematosus, Discoid / drug therapy*
Male
Middle Aged
Rituximab / therapeutic use*
Treatment Outcome

Substances

Rituximab